Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page Users Online: 607
SHORT COMMUNICATION
Year : 2015  |  Volume : 6  |  Issue : 2  |  Page : 33-37

Identification of drug-related problems and pharmacist's interventions in asthmatic patients at a private tertiary care facility-Pakistan


1 Department of Pharmacy Services, Northwest General Hospital and Research Center, Peshawar, Pakistan
2 Department of Medicines and Allied, Northwest General Hospital and Research Center, Peshawar, Pakistan

Correspondence Address:
Aziz Ullah Khan
Department of Pharmacy Services, Northwest General Hospital and Research Center, Sector A3, Phase V, Hayatabad, Peshawar
Pakistan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2045-080X.155511

Rights and Permissions

Background: Drug-related problems (DRPs) potentially contribute to morbidity, mortality and financial indicators. There is increasing evidence that participation and interventions of clinical pharmacists in health care have a positive influence on clinical practice. Objectives: The main focus of this study was to identify DRPs, evaluate clinical pharmacy services and document pharmacist's interventions. Materials and Methods: A 3 months prospective observational study from October, 2014 to January, 2015 was carried out on 80 asthmatic patients admitted to pulmonology unit at Northwest general hospital and research center, Peshawar, Pakistan. The drug therapy details of the patients were collected from inpatient treatment charts using a predesigned questionnaire. The DRPs were identified, and clinical interventions made by pharmacists were documented. Results: A total of 37 patients (61.25%) presenting 91 DRPs were identified, including potential drug-drug interactions 39 (48.75%), drug selection 27 (33.75%), drug use process 12 (15%), drug monitoring 5 (6.25%), adverse drug reactions 5 (6.25%) and dosing 3 (3.75%). Clinical interventions documented by pharmacist were drug information response 21 (26.25%), patient education and counseling 14 (17.5%), change/clarify medication order 11 (13.5%), proper storage and cost effectiveness 10 (12.5%), medication error/brand duplication 7 (8.75%), change of drug/dosage 3 (3.75%), dose calculation in special population 3 (3.75%) and discharge plan 2 (2.5%). Of 91 interventions, the pharmacists contacted the consultants for 24 (30%) interventions, postgraduate medical officers/registrars 34 (42.5%), nursing staff 21 (26.25%) and the patients/attendant 12 (15%). 15 (18.75%) interventions were approved by concerned prescribers. Conclusion: To minimize the risks of DRPs and prevent their occurrence, drug therapy requires pharmacist's timely and effective interventions at all levels.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3898    
    Printed108    
    Emailed11    
    PDF Downloaded403    
    Comments [Add]    

Recommend this journal